Adlai Nortye Ltd. announced that the first patient was dosed in the Phase II clinical trial known as ARTEMIS . This clinical study evaluates palupiprant , a small molecule prostaglandin E receptor 4 .
UWI honours top scientists, researchers - Trinidad and Tobago Newsday newsday.co.tt - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsday.co.tt Daily Mail and Mail on Sunday newspapers.